Track the ARIAD PHARMACEUTICALS INC share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €84.9m. The latest transaction was filed on 9 February 2016 (Attribution). Among the most active insiders: BERGER HARVEY J M D. The full history is openly available.
33
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
8 ops.
Sell Volume
Fundamental score
Ranked 17,028 of 29,062 companies
46.9
score / 100
Value
43
Quality
51
FCF yld-8.6%
Earn yld5.1%
EV/EBITDA12.5x
ROE3.6%
Gross mgn·
Net mgn4.1%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ARIAD PHARMACEUTICALS INC es una empresa biofarmacéutica enfocada en el desarrollo de tratamientos para el cáncer. Se especializa en terapias dirigidas para mejorar los resultados de los pacientes.